Best Healthcare Research Agencies in Japan
Which of the healthcare research agencies in Japan fits your brief? 7 providers scored on verification, data quality and compliance for 2026.
Quick answer
For deep-tier physician recruitment, Global Vox Populi; for large-scale patient and consumer data, Kantar; for specialized regulatory and market access consulting, Seed Planning; and for integrated clinical and commercial intelligence, IQVIA.
Selecting the right research partner is a decision that dictates the success of market entry and product positioning for pharmaceutical, medtech, and health-system clients. The environment for healthcare research agencies in Japan requires a nuanced understanding of a medical environment where traditional hospital structures, unique reimbursement models, and stringent regulatory compliance influence every data collection effort.
Decision-makers must weigh the benefits of global reach against the necessity of local cultural calibration and verified access to hard-to-reach healthcare professionals. This assessment provides a comparative view of firms active in the Japanese market, focusing on their proprietary capabilities and their ability to translate local medical insights into actionable strategy for global life-sciences organizations.
Best Healthcare Research Agencies in Japan: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | Global Vox Populi | Verified physician and low-incidence recruitment | 90.5 |
| 2 | M3 Global Research | Large-scale physician fieldwork and quantitative HCP research | 89.0 |
| 3 | IQVIA | Integrated real-world evidence and commercial launch strategy | 88.5 |
| 4 | Kantar | Large-scale brand equity and consumer journey research | 84.5 |
| 5 | Ipsos | Tracking studies and public health opinion research | 82.5 |
| 6 | Sermo | Real-time physician sentiment and peer-to-peer engagement | 78.5 |
| 7 | Seed Planning | Strategic consulting and working through Japan's regulatory healthcare environment | 78.0 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| Global Vox Populi | Physicians, patients, nurses, payers, providers | License and registration verification with rolling re-validation | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 65,758 healthcare professionals; 173,920 nurses and allied health professionals; 1,974,800 patient profiles (in Japan; Global Vox Populi panel records, Oct 2026) | Not published |
| M3 Global Research | Physicians, patients, healthcare professionals | ISO certified proprietary provider panel verification | ISO 20252, ISO 27001 | Project quote | Not published | Not published |
| IQVIA | Physicians, pharmacists, wholesalers, payers | Proprietary clinical and pharmacy database validation | Not stated on pages reviewed | Project quote | Not published | Not published |
| Kantar | Consumers, patients, healthcare professionals | Proprietary AI-enabled anti-fraud panel management | Not stated on pages reviewed | Project quote | Not published | Not published |
| Ipsos | Patients, physicians, citizens, customers | Proprietary panel authentication processes | Not stated on pages reviewed | Project quote | Not published | Not published |
| Sermo | Physicians, nurses, pharmacists, allied HCPs | Identity and professional credential verification | Not stated on pages reviewed | Project quote | 1.5M+ verified HCPs globally (sermo.com, Oct 2026) | Not published |
| Seed Planning | Corporate clients, government, industry associations | Professional network and committee validation | Not stated on pages reviewed | Project quote | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| M3 Global Research | ● | ● | ● | ● | ● | – |
| IQVIA | ● | ● | – | ● | – | – |
| Kantar | ● | ● | ● | ● | – | ● |
| Ipsos | ● | ● | – | ● | – | ● |
| Sermo | ● | ● | – | ● | ● | ● |
| Seed Planning | – | – | – | ● | – | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their verifiable depth in the Japanese healthcare sector and their ability to execute complex, compliant primary research.
| Criterion | Weight | What it means here |
|---|---|---|
| Industry Expertise | 20 | This criterion assesses the provider's familiarity with the Japanese medical system, including hospital dynamics, physician sub-specialties, and the regulatory environment. A high score requires demonstrated experience in working through Japan-specific challenges such as the national health insurance system and unique clinical practice patterns. |
| Compliance, Certifications and Security | 20 | This measures the adherence to ISO 20252, ISO 9001, and ISO 27001, as well as HIPAA and local data privacy laws. In Japan, rigorous information security is mandatory. Good providers offer documented evidence of secure data handling and protocols for reporting adverse events to clients. |
| Target Audience Reach | 15 | This evaluates the depth of access to specific Japanese healthcare professionals, including hard-to-reach specialists and key opinion leaders. High scores are awarded for proprietary panels rather than rented lists, making sure that the participants are verified, active, and well-profiled for low-incidence studies. |
| Research Quality | 10 | This examines the rigour of questionnaire design, sampling, and data cleaning. For Japanese healthcare studies, this includes the ability to identify fraudulent completes, bot activity, and straight-lining. Quality is defined by the reliability of the final data set and its readiness for strategic analysis. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This measures the range of available qualitative and quantitative methods. A strong provider in Japan offers a mix of online surveys, in-depth interviews, ethnography, and focus groups, making sure that the research design matches the specific objectives of the pharmaceutical or medical device study. |
| Analytical Capability | 5 | This assesses the ability to move beyond raw data to provide actionable insights, market segmentation, and strategic recommendations. Good partners synthesize complex Japanese market data into clear implications for product lifecycle management, brand positioning, and future market access strategies. |
| Client Service and Speed | 5 | This evaluates the responsiveness and project management capabilities of the local team. In the Japanese context, service quality is defined by clear communication, proactive reporting on fieldwork progress, and the ability to manage complex logistics while meeting tight project timelines. |
| Pricing and Feasibility Transparency | 5 | This assesses the honesty and clarity regarding project feasibility, incidence rates, and costs. High-performing agencies provide upfront, realistic assessments of what is achievable in the Japanese market, protecting alignment between research goals and the budget required for high-quality data collection. |
Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: healthcare research agencies in Japan
Global Vox Populi: best for verified physician and low-incidence recruitment
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant

Strongest fitSuits global pharmaceutical and medtech teams requiring high-integrity, verified healthcare professional and patient data for critical business decisions.
Global Vox Populi operates as a dedicated research partner for life-sciences clients, maintaining extensive proprietary panels in Japan. Its infrastructure supports complex primary research by combining rigorous validation protocols with a deep, segmented understanding of the local medical environment.
The company provides access to 65,758 healthcare professionals in Japan, including 24,616 primary care physicians and 4,638 surgical specialists. Additionally, it maintains a patient panel of 1,974,800 profiles and a specialized network of 1,810 payers and providers, making sure that researchers can reach precise target groups for both quantitative and qualitative studies.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Japan
65,758 panellists
- Primary & General24,616
- Internal Medicine Subspecialties7,362
- Diagnostic & Laboratory4,746
- Acute, Peri-operative & Critical Care4,694
- Surgical Specialties4,638
- Women's & Reproductive Health4,260
Nurses and allied health panel, in Japan
173,920 panellists
- Registered Nurses61,828
- Advanced Practice Nurses2,769
- Licensed / Practical / Enrolled Nurses13,763
- Nursing Support (Aides / HCAs)4,192
- Midwives4,926
- Pharmacists & Pharmacy Techs13,202
Patient panel, in Japan
1,974,800 patient profiles
- Aesthetics & Cosmetic622,398
- Cardiovascular161,807
- Ophthalmology124,230
- Endocrinology & Metabolic119,256
- Dermatology95,877
- Women's Health85,935
Across 731 conditions; a patient with more than one condition is counted once per condition.
Payers and providers panel, in Japan
1,810 panellists
- Provider: Access & Administrative Roles1,086
- Payer: Access & Coverage Roles724
Scorecard: 90.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 10/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Research Quality | 10 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Analytical Capability | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 90.5 |
Core services
- Healthcare Professional Recruitment: Provides access to healthcare professionals across 70+ specialties, including internal medicine and acute care.
- Patient and Caregiver Studies: Supports deep-dive research through a patient panel covering major therapeutic areas such as cardiovascular and endocrinology.
- Payer and Provider Insights: Offers targeted access to payers and providers to evaluate market access and reimbursement dynamics.
- Nursing and Allied Health: Maintains a panel of nurses and allied health professionals, including registered nurses and pharmacists.
Strengths
- Proprietary Panel Depth: Offers granular targeting across 190 markets, with 65,758 verified HCPs and 173,920 nurses in Japan, protecting high-quality, non-rented sample sources.
- Rigorous Data Validation: Employs identity fingerprinting, geo-checks, and trap questions to remove bots and fraudulent completes before delivery.
- Regulatory Compliance: Operates under ISO 9001, ISO 20252, and ISO/IEC 27001 certifications, protecting HIPAA compliance and adherence to international research codes.
Innovation and technology
- Proprietary Data Platform: Surveys are programmed and hosted on a custom-built platform designed for complex healthcare research and secure data management.
- Advanced Profiling: Panel members are profiled across 45 to 140 data points, allowing for precise low-incidence targeting in complex therapeutic areas.
Impact on businesses
- Strategic Decision Support: Helps global life-sciences clients refine launch strategies, evaluate market access barriers, and improve patient outcomes through evidence-led insights.
Why it may fit your brief
The firm is a strong fit for complex studies where participant verification and panel quality are essential. Clients needing broad, general consumer research may find broader-based agencies more suitable for their specific non-healthcare requirements.
M3 Global Research: best for large-scale physician fieldwork and quantitative HCP research

Strongest fitIdeal for projects requiring rapid, large-scale quantitative access to verified physicians in the Japanese market.
M3 Global Research is deeply integrated into the Japanese medical community, using a proprietary provider panel to deliver quantitative and qualitative fieldwork. The firm supports pharmaceutical and life-sciences clients with targeted recruitment for market access, commercialization, and product launch strategies.
With a focus on data quality and compliance, the company holds ISO 20252 and ISO 27001 certifications, making sure that research projects meet stringent security and quality standards. Its ability to combine large-scale volume with verified expertise makes it a primary choice for physician-focused research in Japan.
Scorecard: 89.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | m3global.com (1 page reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | m3global.com (1 page reviewed), Oct 2026 |
| Target Audience Reach | 15 | 10/10 | m3global.com (1 page reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | m3global.com (1 page reviewed), Oct 2026 |
| Market Presence | 10 | 9/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | m3global.com (1 page reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | m3global.com (1 page reviewed), Oct 2026 |
| Client Service and Speed | 5 | 9/10 | m3global.com (1 page reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | m3global.com (1 page reviewed), Oct 2026 |
| Weighted score | 100 | 89.0 |
Core services
- Quantitative Fieldwork: Executes large-scale online surveys with verified healthcare professionals across various medical specialties.
- Qualitative Interviews: Conducts in-depth interviews and focus groups to gain nuanced insights into physician decision-making.
- Targeted Recruitment: Uses the M3 Panel to reach specific physician segments for pharmaceutical and medical device studies.
- Full-Service Project Management: Provides end-to-end support, including survey programming and respondent management for healthcare research.
Strengths
- Largest Physician Panel: Operates an extensive proprietary panel of verified healthcare professionals, protecting high-quality respondent access.
- Stringent Compliance: Holds ISO 20252 and ISO 27001 certifications, with annual audits by independent third parties.
- Local Market Integration: Deeply embedded in the Japanese medical community, providing rapid, reliable access to target audiences.
Innovation and technology
- Technology-Led Fieldwork: Layers innovation and industry knowledge to deliver remote and in-person methodologies.
- Quality Assurance Processes: Implements rigorous industry training and compliance standards for all team members.
Impact on businesses
- Actionable Insights: Drives improvements in global patient outcomes by providing high-quality, reliable medical research data.
Why it may fit your brief
M3 Global Research is a strong fit for high-volume physician surveys. Projects requiring deep, long-term strategic consulting may benefit from firms with a broader consulting focus.
IQVIA: best for integrated real-world evidence and commercial launch strategy

Strongest fitIdeal for large pharmaceutical companies needing extensive data-driven support for clinical development and commercial launch in Japan.
IQVIA maintains a significant footprint in Japan, offering a unified platform that connects proprietary datasets, including hospital and real-world evidence, with advanced analytics. The firm supports pharmaceutical and medical device companies through the entire product lifecycle, from clinical trial design to commercial execution.
Its Japanese operations integrate local regulatory knowledge with global intelligence, assisting organizations in maximizing asset value. By combining functional service provider models with sophisticated AI-driven insights, IQVIA provides a cohesive environment for managing clinical trials and commercial strategies in the local market.
Scorecard: 88.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 88.5 |
Core services
- Clinical Development Solutions: Provides full-service clinical trial management, including site identification and patient recruitment strategies.
- Real World Evidence: Uses extensive hospital databases to generate real-world evidence, supporting market access and product performance analysis.
- Commercial Intelligence: Offers market access strategies and physician behavior insights to optimize commercial execution and launch planning.
- Information Partner Services: Consults with pharmacy and wholesaler partners to assess market opportunities and monitor customer program performance.
Strengths
- Proprietary Data Network: Accesses petabytes of non-identified patient records and proprietary datasets to drive evidence-based strategy.
- Functional Support Models: Deploys flexible FSP solutions to augment clinical operations, protecting quality and regulatory compliance.
- AI-Driven Platforms: Uses agentic AI and predictive models to improve trial efficiency and commercial decision-making.
Innovation and technology
- IQVIA.ai Platform: Integrates data, technology, and analytics to provide a unified agentic platform for life-science organizations.
- Life Science Models: Uses predictive clinical development tools to forecast outcomes and mitigate risks in trial design.
Impact on businesses
- Asset Maximization: Increases the probability of success for assets by connecting insights and expertise across the development lifecycle.
Why it may fit your brief
IQVIA fits complex, data-heavy projects where proprietary databases are required. Smaller, boutique research tasks may find its comprehensive, end-to-end model more extensive than necessary.
Kantar: best for large-scale brand equity and consumer journey research

Strongest fitBest for brand managers seeking large-scale consumer insights and brand health tracking in the Japanese healthcare space.
Kantar Japan provides specialized healthcare research services by combining global patient-reported outcomes databases with local fieldwork expertise. The firm supports international and domestic clients in understanding brand positioning, innovation, and creative effectiveness within the Japanese market.
Its methodology is anchored in proprietary frameworks that analyze human behavior, making sure that insights are culturally calibrated. With a focus on both quantitative survey solutions and qualitative research design, Kantar helps clients work through the complex healthcare environment through data-driven storytelling and actionable dashboards.
Scorecard: 84.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 84.5 |
Core services
- Brand Equity Research: Uses the BrandZ study framework to provide established brand valuation and equity analysis.
- Custom Survey Solutions: Delivers solid insights through custom programming tools and integrated fieldwork management for diverse consumer groups.
- Creative Effectiveness: Analyzes advertising performance across media channels to drive return on investment and brand predisposition.
- Connected Data Solutions: Integrates survey data with third-party and first-party sources for a holistic view of the customer journey.
Strengths
- Global Panel Scale: Operates proprietary Premium Panels globally, allowing for solid sampling and consistent data collection in Japan.
- Advanced Anti-Fraud Tech: Uses Qubed AI to detect fraudulent activity in real time, protecting the integrity of consumer feedback.
- Meaningful Frameworks: Applies behavioural science frameworks to turn data into meaningful business outcomes for brands.
Innovation and technology
- Qubed AI: A next-generation technology designed to stop panel fraud using deep neural networks and machine learning.
- Kantar Marketplace: An agile research platform combining survey products with powerful analytics for faster insights.
Impact on businesses
- Brand Growth: Enables businesses to build strong, sustainable brands through a deeper understanding of consumer behavior.
Why it may fit your brief
Kantar is ideal for projects focused on consumer health and mass-market perceptions. Highly specialized physician-only clinical studies might be better served by clinical-focused agencies.
Ipsos: best for tracking studies and public health opinion research

Strongest fitWell-suited for clients requiring longitudinal tracking of brand health or public perception within the Japanese healthcare system.
Ipsos maintains an active presence in Japan, where it specializes in tracking studies, patient and physician insights, and public opinion. The firm uses a combination of survey data, social media analysis, and qualitative research to provide actionable information for decision-makers in the healthcare sector.
The company emphasizes a partnership approach, working closely with clients to understand their business challenges. By using specialized services such as Ipsos UU for qualitative work, the firm delivers insights that help global pharmaceutical and healthcare clients work through market trends and public sentiment in Japan.
Scorecard: 82.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 82.5 |
Core services
- Market Strategy Research: Provides understanding of market dynamics and competitor environments to support strategic business decisions.
- Brand Health Tracking: Monitors brand performance over time to assess market perception and inform marketing strategies.
- Qualitative Research: Uses the Ipsos UU methodology to uncover deep customer and patient insights through qualitative exploration.
- Public Health Tracking: Tracks perceptions of healthcare systems and public health issues, as seen in its global health service reports.
Strengths
- Global Trends Expertise: Uses extensive global data and trends analysis to provide context for Japanese market research.
- Diverse Methodology: Combines survey data with social media listening and online communities for comprehensive insights.
- Client-Centric Partnerships: Focuses on long-term relationships and deep understanding of client business challenges.
Innovation and technology
- Augmented Ipsos: Incorporates AI and advanced analytics to deliver insights more consistently and rapidly across markets.
- True Understanding Framework: Applies scientific rigor to turn information into actionable truth for better decision-making.
Impact on businesses
- Confident Decision Making: Helps clients act faster and smarter by providing reliable, accurate information on public and market sentiment.
Why it may fit your brief
Ipsos excels in broad-scale tracking and public opinion research. For highly technical clinical trial recruitment or niche KOL mapping, specialized clinical panels may be preferred.
Sermo: best for real-time physician sentiment and peer-to-peer engagement

Strongest fitBest for clients needing rapid, real-time physician sentiment and qualitative feedback on specific clinical or commercial topics.
Sermo supports direct access to a large, verified community of physicians and healthcare professionals in Japan. Its platform supports real-time surveys and qualitative discussions, enabling pharmaceutical and medical device clients to gain rapid perspectives on clinical practice and medical developments.
With a physical presence in Tokyo, the company combines its global technology network with local engagement, helping clients understand the needs and opinions of the Japanese medical community. The platform is designed to provide frictionless access to practitioner sentiment, fostering better-informed decisions for brand and lifecycle management.
Scorecard: 78.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 78.5 |
Core services
- Physician Insights: Provides quick access to physician sentiment through surveys and qualitative engagement tools.
- Medical Community Engagement: Connects clients with a verified network of HCPs to gather real-world perspectives on clinical practice.
- Real-Time Research: Supports rapid data collection through online surveys tailored to physician specialties.
- Career and Professional Development: Supports HCPs with resources on career development, providing a channel for professional insights.
Strengths
- Large Verified Community: Reaches over 1.5 million verified healthcare professionals globally, including a strong presence in Japan.
- Compliance Processes: Maintains proprietary verification and compliance standards to protect high-quality, actionable insights.
- Direct HCP Access: Allows for frictionless engagement with physicians for rapid feedback on medical and commercial questions.
Innovation and technology
- Health Tech Network: Integrates research and engagement solutions within a global digital community for verified HCPs.
- Sentiment Series: Produces research reports in partnership with industry to track changing healthcare dynamics.
Impact on businesses
- Business Transformation: Helps brands drive business success by providing direct, rapid access to physician perspectives.
Why it may fit your brief
Sermo is highly effective for quick-turnaround physician engagement. Projects requiring complex, multi-year strategic consulting or patient-centric ethnography may be better suited to other agencies.
Seed Planning: best for strategic consulting and working through Japan's regulatory healthcare environment

Strongest fitIdeal for companies needing deep strategic consulting and regulatory navigation within the Japanese healthcare sector.
Seed Planning provides specialized consulting and research services that help international clients work through Japan’s regulatory, reimbursement, and hospital systems. With roots dating back to 1983, the firm offers deep local expertise and bilingual execution for high-value strategic projects.
The company balances market research with consulting, providing not only data but also actionable recommendations for business challenges. Its work covers a broad range of topics, including medical technology, AI in healthcare, and the evolution of hospital systems, making it a key partner for strategic planning in Japan.
Scorecard: 78.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | seedplanning.co.jp (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | seedplanning.co.jp (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | seedplanning.co.jp (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | seedplanning.co.jp (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | seedplanning.co.jp (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | seedplanning.co.jp (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | seedplanning.co.jp (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | seedplanning.co.jp (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 78.0 |
Core services
- Strategic Consulting: Offers high-value consulting services for business problem solving and execution strategy planning.
- Market Research Reports: Publishes proprietary research reports on healthcare trends, medical technologies, and market dynamics.
- Regulatory Advisory: Assists clients in working through Japan's policy and regulatory environment for healthcare and life sciences.
- Back Office Support: Supports industry associations and committees through operational and reporting expertise.
Strengths
- Deep Local Expertise: Uses four decades of experience in the Japanese market to provide nuanced strategic guidance.
- Balanced Consulting Approach: Combines primary market research with strategic consulting to provide actionable recommendations.
- Comprehensive Network: Maintains extensive connections with domestic industry bodies, government agencies, and research institutions.
Innovation and technology
- Future Medicine Forums: Hosts forums to discuss emerging medical technologies and the future of healthcare in Japan.
- Trend Forecasting: Provides insight into emerging sectors like regenerative medicine and AI-driven hospital infrastructure.
Impact on businesses
- Strategic Problem Solving: Enables clients to resolve business challenges and plan for future market shifts in Japan.
Why it may fit your brief
Seed Planning is an excellent partner for strategic advisory projects. Organizations requiring high-volume online quantitative fieldwork may prefer dedicated panel-based research providers.
How HCP and patient verification actually works in Japan
Protect all healthcare research agencies in Japan use multi-layered verification processes including license matching and rolling re-validation.
License and Registration Checks
The foundation of reliable healthcare research in Japan is the verification of medical licenses against official databases. Buyers should request proof that the agency checks the registration status of every physician and nurse in their panel. This makes sure that participants are genuine, active practitioners. Agencies failing to perform these checks risk compromising data quality, as non-verified respondents may misrepresent their clinical experience.
Rolling Re-validation
Verification is not a one-time event. High-performing agencies perform rolling re-validation of their panels to make sure that credentials remain current and that respondents are still active in their reported specialties. Ask for details on how often the provider updates their professional records. A stale panel is a significant risk, as it may include individuals who have retired or changed practice areas, rendering their insights irrelevant for current market studies.
Identity and Fraud Detection
Beyond credentials, digital identity verification is essential to prevent professional impersonation. Agencies should employ device and identity fingerprinting to make sure that one person is not participating multiple times or using a proxy. Request information on how the provider identifies and removes fraudulent completes, specifically regarding the use of trap questions and speed-check algorithms to identify non-human or dishonest activity.
Ethical Consent Protocols
Transparency in consent is a hallmark of compliant research. Verify that the agency uses a double opt-in process where participants explicitly agree to the terms of each study. This is essential for compliance with both local data protection laws and international standards such as GDPR or HIPAA. Ask to review the agency's participant privacy policy to make sure that data is handled with the appropriate level of security and that consent is revocable.
How to choose the right provider in Japan
Select a partner by aligning their primary methodology with the specific stage and objective of your research project.
- Define Research Objectives: Clearly distinguish between the need for large-scale quantitative tracking and deep-dive qualitative insights. Choose a provider whose panel size and methodological strengths align with your primary data collection requirements.
- Assess Local Knowledge: Confirm the provider's experience with the Japanese medical system, including reimbursement models and referral networks. A partner with a physical presence or long-standing local history is often better equipped to manage cultural nuances.
- Verify Data Quality: Request a summary of the provider's quality control protocols. High-quality agencies will have clear, documented procedures for removing fraudulent responses and protecting respondent accuracy.
- Evaluate Compliance Standards: Make sure the agency holds relevant certifications such as ISO 20252 and adheres to local privacy regulations. This is non-negotiable for healthcare research involving sensitive patient or provider data.
- Request Feasibility Proof: Ask for a feasibility check for your target audience before committing to a project. A reputable firm will provide an honest assessment of incidence rates and the time required for recruitment.
Questions to ask before you commission
- What is your specific process for verifying the medical credentials of Japanese physicians in your panel?
- How do you handle low-incidence recruitment for rare-disease patients or specialized medical roles in the Japanese market?
- Can you provide your most recent audit report or certification details for ISO 20252 and ISO 27001?
- What specific measures do you take to detect and remove bot activity and fraudulent completes in your online surveys?
- How does your local team in Japan manage communication and project management for international clients?
- What is your protocol for reporting adverse events or product complaints discovered during fieldwork?
Common pitfalls to avoid
- Relying on Generalist Panels: Using consumer-focused research firms for healthcare studies often leads to poor data quality and difficulty reaching verified medical professionals.
- Ignoring Local Compliance: Failing to prioritize local data protection and regulatory standards can lead to significant legal risk and project delays.
- Overlooking Verification Depth: Assuming that a large panel size equates to high-quality data without verifying the authentication process is a common and costly error.
- Neglecting Cultural Nuance: Ignoring the specific communication styles and professional hierarchies within the Japanese medical community can result in unusable research findings.
What a feasibility check should include
A reliable feasibility check must account for the specific incidence rate of the target audience within the Japanese healthcare system.
Incidence Rate Analysis
Protect the provider calculates the incidence rate based on the actual availability of the target segment in Japan. Overestimating the number of available physicians or patients often leads to significant delays during fieldwork.
Panel Composition Review
Ask to see a breakdown of the panel by specialty or patient condition. This confirms whether the provider has the depth required for your specific study rather than just a large total panel size.
Recruitment Timeline Assessment
Require a realistic timeline that accounts for the time needed to verify credentials and achieve high-quality completes. Avoid providers that promise unrealistic turnaround times for complex audiences.
Budgetary Alignment
Verify that the quoted costs are based on the actual difficulty of reaching the target group. A transparent provider will explain why certain segments carry higher recruitment costs.
Conclusion
Choosing among healthcare research agencies in Japan requires a balance between technical data requirements and the need for localized medical expertise. For large-scale quantitative studies and brand tracking, established providers with vast consumer and physician panels offer the necessary volume and reach. However, for specialized clinical research, medtech product development, or sensitive patient-reported outcomes, firms that emphasize proprietary panel ownership and rigorous verification are the most reliable partners.
Use the scorecard above to filter providers by your specific study type. If your research involves low-incidence physician groups or critical strategic decisions, prioritize firms that demonstrate high scores in industry expertise and compliance. Always request a formal feasibility check before commencing, as this provides a clear view of the provider’s actual capabilities and the expected data quality for your project.
Planning research in Japan? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
Which healthcare market research agency is best for the Japanese market?
There is no single best agency, as the choice depends on your project needs. Global Vox Populi is highly effective for verified physician recruitment and low-incidence studies, while IQVIA excels in data-driven commercial intelligence. Seed Planning offers deep strategic consulting, and larger firms like Kantar or M3 Global Research are well-suited for high-volume brand tracking and physician fieldwork.
How does the Japanese healthcare system impact market research?
The Japanese healthcare system is highly regulated, with specific reimbursement models and hierarchical medical structures that influence how physicians participate in research. Understanding these dynamics is essential for designing effective studies, making sure that recruitment strategies respect local professional norms and that data collection remains compliant with strict privacy regulations.
Are there specialized healthcare research firms in Tokyo?
Yes, several firms maintain dedicated healthcare research teams in Tokyo. Specialist firms like Seed Planning have deep local roots, while larger international providers like IQVIA, Kantar, Ipsos, and Sermo maintain local offices to support direct access to the Japanese medical community and make sure that research is culturally and regulatory compliant.
How to conduct pharmaceutical market research in Japan?
Conducting successful pharmaceutical research in Japan requires a mix of local expertise and rigorous methodology. Start by identifying the right target audience, whether it is physicians, patients, or payers, and make sure they are verified. Use a partner that understands the local regulatory environment and can work through the unique challenges of the Japanese healthcare system through compliant, evidence-led fieldwork.
What are the requirements for HCP recruitment in Japan?
HCP recruitment in Japan requires stringent verification of medical licenses and professional registrations. Recruitment must be conducted ethically, often through professional associations or verified medical registries. High-quality research requires that participants are not only verified at the point of entry but also subject to rolling re-validation to make sure their credentials and practice areas remain current.
Is it necessary to use a local research agency in Japan?
While global agencies can manage projects remotely, using a partner with a local presence or established local network is highly recommended. A local agency understands the cultural nuances of the medical community, protects adherence to local data protection laws, and can provide the necessary strategic context to interpret research findings effectively within the Japanese market.
What are the costs of healthcare market research in Japan?
Costs for healthcare market research in Japan are project-dependent and vary based on the complexity of the target audience, the methodology used, and the required turnaround time. Specialized physician recruitment and patient-reported outcomes studies typically command higher fees due to the difficulty of access and the need for rigorous verification processes compared to general consumer research.
What is the importance of ISO certifications in this field?
ISO certifications like ISO 20252 and ISO 27001 are indicators of a firm's commitment to research quality and information security. In the sensitive area of healthcare, these certifications provide assurance that the agency follows standardized, secure processes for handling data, managing participant privacy, and protecting the reliability of the research results, which is essential for life-science clients.